Thyroid cancer is the most prevalent endocrine tumor and its incidence is fast-growing
worldwide in recent years. Differentiated thyroid cancer (DTC) is the most common …

Simple Summary Increased oxidative stress (OS) has been implicated as a relevant risk
factor for cancer development and progression. The incidence of differentiated thyroid …

Purpose: Medullary thyroid cancer (MTC) accounts for about 2% of all thyroid cancer, but
has a relatively poor prognosis compared with differentiated thyroid cancer. Anlotinib is a …

Background: Surgery is the primary treatment for locally advanced thyroid cancer. For some
cases, R0/R1 resection could not be achieved at initial diagnosis and neoadjuvant treatment …

Naturally occurring canine cancers have remarkable similarities to their human counterparts.
To better understand these similarities, we investigated 671 client-owned dogs from 96 …

Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery,
chemotherapy, radiotherapy, and radioactive iodine (RAI) therapy are the standard TC …

Background: Selpercatinib, a highly selective and potent REarranged during Transfection
(RET) kinase inhibitor, is effective in advanced RET-altered thyroid cancer (TC). However …

Purpose Papillary thyroid carcinoma (PTC) progression imparts reduced patient survival.
Tumor resistance and progression can be influenced by Glutathione (GSH) metabolism …

Background Thyroid cancers are the most common endocrine malignancies with a dramatic
increase in incidences. Anaplastic thyroid cancer is a rare but deadly form among thyroid …

In this report, we present a high-grade thyroid carcinoma with an NSD3:: NUTM1 fusion
detected on expanded next-generation sequencing testing. Nuclear protein of the testis …